Secondary Research – Potential Growing Markets
Transparency Market Research (TMR) estimates that global urinary drainage catheter market sales in 2016 to have been approximately $3 billion and expected this to expand at a steady CAGR of above 5% over the forecast period from 2017 to 2025 to reach a sales value of around $5 billion in 2025.  Of course, that is only the urinary drainage catheter market, and UroPharma will also derive significant revenue from the drugs that will be sold in combination with the dtb-instilla.
According to research carried out in 2018 by Cleveland Clinic (a reputable non-profit academic medical center), there is an estimated 2.5 million people with Multiple Sclerosis (MS) worldwide and 1 million in the US alone;  although this US estimate is substantially higher than others.
We have based our market projections on an estimated of 400,000 people with MS in North America.  Additionally, the Multiple Sclerosis International Federation (MSIF) estimates that 10,000 new cases are diagnosed every year in the US (that’s 200 new cases per week).  Of all those people, it is anticipated that up to 90% will experience bladder problems.